What Labex Canada does

Labex Canada Inc. is a privately held Canadian medical equipment and in-vitro diagnostics company founded in 2011 and headquartered in Newmarket, Ontario. The company manufactures and globally distributes automated laboratory instruments and reagents used in cancer diagnostics, genetic testing, and pathological analysis. Its proprietary product portfolio includes two automated immunohistochemistry stainers (LC-AS20 with 20-slide capacity and LC-AS88 with 88-slide capacity), the LC-FH20 automatic FISH hybridizer, and the LC-DMS32 DNA methylation system. Labex also produces a catalog of over 116 IHC antibodies and approximately 500 FISH probes, 40 of which carry Health Canada certification for IHC antibodies and 3 for FISH probes.

The company operates a hybrid manufacturer-distributor business model. Beyond its own manufactured instruments and reagents, Labex serves as the exclusive global sales and marketing representative for Sycan Medtech (coagulation analyzers), Syscan Biotech (coagulation reagents), Long Island Antibodies Diagnostica (IHC/FISH products), and Beckman Coulter ELISA immunoassay kits in over 10 countries across South America, the Middle East, and Africa. Distribution is executed through a network of 25+ professional distributors across more than 20 countries, with Labex providing sales training and after-sales support. The company also offers Complete Laboratory Solutions, a turnkey modular laboratory setup platform introduced in 2016, and LCCP (Labex Complex Construction Project), a modular healthcare facility construction service launched in 2018.

Revenue is generated primarily through one-time hardware sales, recurring consumable sales tied to installed instruments, and project-based service fees for laboratory and healthcare facility solutions. The company manufactures COVID-19 diagnostic kits in its Ontario facility, which holds ISO 13485:2016 and MDSAP certifications. Labex has obtained Health Canada Medical Device Establishment Licence, CE/IVDR, and CE/IVDD certifications, enabling international market access. The company remains privately held with no disclosed institutional funding or revenue figures, and reports 1-10 employees.

Name

Labex Canada

Legal name

Labex Canada Inc.

Website

https://labexcanada.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

1–10 employees

Short description

Labex Canada manufactures and globally distributes automated IHC stainers, FISH hybridizers, and DNA methylation systems, plus a catalog of IHC antibodies and FISH probes used by diagnostic laboratories for cancer and genetic testing, through a network of 25+ international distributors.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostic (IVD) Medical Equipment and Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)

akta.pro secondary industries

Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations) (HLAGAIAD), Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)

Keywords

• Medical diagnostic equipment
• In vitro diagnostics
• Immunohistochemistry stainers
• FISH hybridization systems
• DNA methylation analysis

Headquarters

HQ city

Newmarket

HQ country

Canada

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical and Laboratory Equipment Distribution: Import/export/marketing and distribution of products in the fields of medical and laboratory instrumentation, reagents, and test kits. Products are sold globally through distributor networks.
2. IVD Products Sales: Sale of IVD products including IHC stainers, FISH hybridizers, DNA methylation systems, antibodies, probes, and reagents. Revenue generated from instrument sales and consumables.
3. COVID-19 Diagnostic Kits: Manufacturing and sale of COVID-19 diagnostic products including RT-PCR kits, rapid antigen tests, and antibody tests. Kits manufactured in Ontario facility.
4. Complete Laboratory Solutions: Offering complete turnkey laboratory solutions in different sizes, standards, and price points. Developed in 2016, this platform offers affordable laboratories sold successfully worldwide.
5. LCCP (Labex Complex Construction Project): Comprehensive range of various packages for the healthcare sector based on modular technology. Customers can choose from individual modules to complete projects including complex ones. Introduced in 2018.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Labex Canada manufactures and globally distributes automated in vitro diagnostic (IVD) laboratory instruments and reagents — including IHC stainers (LC-AS20, LC-AS88), FISH hybridizers (LC-FH20), DNA methylation systems (LC-DMS32), IHC antibodies, FISH probes, DNA methylation kits, and COVID-19 diagnostic kits. The company also designs, plans, and delivers turnkey laboratory and modular healthcare facility solutions (Complete Laboratory Solutions and LCCP).

Product overview

Labex Canada is a medical equipment and IVD company operating as both a manufacturer and distributor. The company manufactures automated laboratory instruments including IHC Stainers (LC-AS20 with 20-slide capacity and LC-AS88 with 88-slide capacity), Automatic FISH Hybridizers (LC-FH20 with 20-slide capacity), and DNA Methylation Systems (LC-DMS32 with 32-sample capacity). In addition to instruments, Labex produces配套 reagents including IHC antibodies (40+ Health Canada certified), FISH probes (67+ products, 3 certified), and DNA methylation kits. The company also distributes Beckman Coulter Elisa kits across South America, Middle East, and Africa. Beyond products, Labex offers Complete Laboratory Solutions (modular laboratory setups) and LCCP (healthcare facility construction projects). All products come with full technical support and are tested in real laboratory conditions.

Differentiator

Problem solved

Functional benefit

Brands

• LAVI Series: Ventilation device with HFT function for intermittent pressure-controlled ventilation of patients, intended for invasive and non-invasive ventilation.
• LCCP (Labex Complex Construction Project)
• Complete Laboratory Solutions

Products and services

• Fully Automatic IHC Stainer LC-AS20 Automated immunohistochemistry staining instrument with 20-slide capacity per run used by pathology and diagnostic laboratories for visualization of pathological conditions in tissues and cells.
• Fully Automatic IHC Stainer LC-AS88 High-throughput automated immunohistochemistry stainer with 88-slide capacity per run featuring programmable operating software for flexible staining protocols, aimed at high-volume diagnostic laboratories.
• Automatic FISH Hybridizer LC-FH20

Quantifiable outcome

• 90% less labor required compared to manual processing with automated FISH Hybridizer
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Four partnerships are on record, tiered core.

• Sycan MedtechcoreTechnology or Integration · 1 January 2019Sycan Medtech is a manufacturer of fully automatic Coagulation Analyzers. In 2019, Labex Canada was appointed as Sales/Marketing department for the entire globe for Sycan Medtech products. This partnership provides Labex with automated coagulation diagnostic equipment for their product portfolio.
• Syscan BiotechcoreTechnology or Integration · 1 January 2019Syscan Biotech is a manufacturer of a wide range of Coagulation reagents. In 2019, Labex Canada was appointed as Sales/Marketing department for the entire globe for Syscan Biotech products. This partnership complements the coagulation analyzer offerings.
• Long Island Antibodies DiagnosticacoreTechnology or Integration · 1 January 2019Long Island Antibodies Diagnostica manufactures fully automatic immunohistochemistry (IHC) stainers, automatic FISH fluorescence in situ hybridization (FISH) hybridizers, and a wide range of primary and secondary antibodies and FISH probes. Appointed as global Sales/Marketing department in 2019.
• Beckman CoultercoreTechnology or IntegrationLabex Canada is the exclusive sales office for over 10 countries in South America, the Middle East, and Africa for Beckman Coulter ELISA immunoassay kits. The portfolio covers reproductive problems (AMH, Inhibin A, Inhibin B, Free Testosterone), allergic conditions (Histamine), diabetes, and specialty topics (Vitamin D, Serotonin, Chromogranin A).

Scale indicators9 records

Recent moves11 records

Expansion highlights5 records

Direct peers

• Sakura Finetek: Sakura Finetek manufactures tissue processing, embedding, and automated IHC staining instrumentation, competing head-to-head with Labex's LC-AS20/LC-AS88 stainers in histology workflow automation.
• BioGenex Laboratories: BioGenex designs and manufactures automated IHC and FISH staining systems and reagent portfolios, overlapping directly with Labex's core IHC/FISH automation and reagent lines.
• Biocare Medical: Biocare Medical develops and manufactures IHC antibodies, FISH probes, and automated staining systems for cancer diagnostics - directly comparable product overlap with Labex's IHC/FISH portfolio and similar niche pathology focus.

Broad incumbents

• Roche Diagnostics (Ventana): Roche's Ventana platform is the global leader in automated IHC and ISH staining and is the standard against which Labex's IHC and FISH systems must compete for hospital lab adoption.
• Leica Biosystems (Danaher): Leica's BOND IHC/ISH stainers, primary antibodies, and FISH probes define the enterprise pathology standard Labex's LC-AS and FISH platforms must displace.
• Dako (Agilent Technologies): Dako/Agilent produces the benchmark IHC antibody catalog (HercepTest, ER/PR, etc.) that competes directly with Labex's 40+ Health Canada-certified antibodies and broader cancer panels.

Emerging players

• Histo-Line Laboratories: Histo-Line produces histology and IHC equipment and reagents at smaller scale than incumbents, overlapping with Labex's specialty-automated instruments and emerging-market distribution model.
• MEDITE Medical GmbH: MEDITE supplies histology, cytology, and IHC workflow instruments and consumables for clinical labs, comparable in product breadth and target customer profile to Labex's Complete Laboratory Solutions offering.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/labexcanada
• Xx.com/labexcanada

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Labex Canada